What is the price-to-earnings ratio of Almirall?
The price-earnings ratio of Almirall is currently 37.26.
Almirall P/E 2024
Almirall P/E
37.26
Ticker
ALM.MC
ISIN
ES0157097017
WKN
A0MU8Y
As of Sep 29, 2024, Almirall's P/E ratio was 37.26, a -187.94% change from the -42.37 P/E ratio recorded in the previous year.
The Almirall P/E history
Almirall Aktienanalyse
What does Almirall do?
The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Almirall's P/E Ratio
The Price to Earnings (P/E) Ratio of Almirall is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Almirall's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Almirall is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Almirall’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Almirall stock
How has the price-earnings ratio of Almirall changed compared to last year?
The price-to-earnings ratio of Almirall has increased by -187.94% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Almirall high compared to other companies?
Yes, the price-to-earnings ratio of Almirall is high compared to other companies.
How does an increase in the price-earnings ratio of Almirall affect the company?
An increase in the price-earnings ratio of Almirall would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Almirall affect the company?
A decrease in the price-earnings ratio of Almirall would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Almirall?
Some factors that influence the price-earnings ratio of Almirall are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Almirall pay?
Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 2.08 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.
What is the dividend yield of Almirall?
The current dividend yield of Almirall is 2.08 %.
When does Almirall pay dividends?
Almirall pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Almirall?
Almirall paid dividends every year for the past 14 years.
What is the dividend of Almirall?
For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 2.05 %.
In which sector is Almirall located?
Almirall is assigned to the 'Health' sector.
Wann musste ich die Aktien von Almirall kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Almirall from 6/12/2024 amounting to 0.184 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
When did Almirall pay the last dividend?
The last dividend was paid out on 6/12/2024.
What was the dividend of Almirall in the year 2023?
In the year 2023, Almirall distributed 0.186 EUR as dividends.
In which currency does Almirall pay out the dividend?
The dividends of Almirall are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Almirall
Our stock analysis for Almirall Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Almirall Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
